# Coya Therapeutics, Inc.: Form 8-K, filed Mar 18, 2025

- Company: [Coya Therapeutics, Inc.](/companies/coya.md) (CIK 1835022)
- Form: 8-K
- Filed: 2025-03-18
- Accepted by EDGAR: Mar 18, 2025, 12:20 ET
- Period: 2025-03-18
- Accession: 0000950170-25-040779
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1835022/000095017025040779/coya-20250318.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1835022/000095017025040779/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1835022/000095017025040779/coya-20250318.htm

Filed Mar 18, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-040779. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.